文献速递老年综合评估衰弱、肌少症与跌倒

老年功能指数(ELFI):癌症患者功能状态的患者报告结局测量工具的多中心前瞻性验证研究

The Elderly Functional Index (ELFI), a patient-reported outcome measure of functional status in patients with cancer: a multicentre, prospective validation study.
PubMed 文献 · Lancet Healthy Longev · 2020-12-17

该多中心前瞻性验证研究在澳大利亚五个肿瘤诊疗机构纳入成年癌症患者,验证老年功能指数(ELFI)——一种基于EORTC QLQ功能量表(躯体、角色、社会功能及活动能力)的12条目自报功能复合测量。ELFI是一种经验证、简便的多维患者报告功能状态测量工具,可作为临床试验终点评估健康相关生活质量的功能维度。

要点

  • ELFI为12条目自报功能复合测量,源自EORTC QLQ躯体、角色、社会功能及活动能力量表。
  • ELFI区分不同功能和衰弱分组的能力优于其分量表及其他功能测量。

核心结论

  • ELFI是经验证、简便的多维患者报告功能状态测量工具,能捕捉广泛的功能维度。
  • ELFI较其分量表具有更高的统计效率,可减少检测特定效应所需的样本量。
  • ELFI可作为临床试验终点评估健康相关生活质量的功能领域。

研究设计与样本

  • 多中心前瞻性验证研究,在澳大利亚五个肿瘤诊疗机构纳入成年癌症患者。
  • 877名参与者返回869份基线问卷和482份重测问卷;621名(71%)参与者(192名[31%]年龄≥70岁)纳入效度和内在一致性评估。
  • 278名(32%)参与者(106名[38%]年龄≥70岁)纳入重测信度评估。
  • 基线自评ELFI、EORTC QLQ Core-30认知和情绪功能量表、ECOG-PS、IADL和临床衰弱量表(CFS);部分参与者在1周后重测ELFI等并完成总体变化评级。

主要发现

  • ELFI在区分不同功能和衰弱评分分组方面优于其分量表和其他功能测量(已知组效度)。

关键数值与推荐

  • ELFI为12条目复合测量,源自EORTC QLQ的躯体、角色、社会功能及活动能力量表。

临床怎么用

  • ELFI可用于老年癌症患者功能状态的自报评估,补充临床医生评估。
  • ELFI可作为临床试验终点评估健康相关生活质量的功能维度。
  • ELFI统计效率优于其分量表,有助于减少临床试验所需样本量。

局限性

  • 研究在澳大利亚五个肿瘤诊疗机构开展,外推至其他地区需谨慎。
  • 效度和内在一致性评估中年龄≥70岁者仅占31%,重测信度评估中占38%。
  • 重测信度评估仅纳入选择重复测量的参与者(278名,32%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Functional assessment of patients with cancer can be challenging and is often undertaken by the clinician with minimal direct input from the patient. We developed and aimed to validate the Elderly Functional Index (ELFI), a composite measure of self-reported functioning in older patients with cancer. METHODS: In this multicentre, prospective validation study, we validated ELFI in adult patients attending five oncology practices in Australia. ELFI is a 12-item composite measure of self-reported functioning derived from functional scales of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ): physical, role, and social functioning, and mobility. For evaluation of validity and internal consistency, participants self-completed ELFI, cognitive functioning and emotional functioning scales of the EORTC QLQ Core-30, Eastern Cooperative Oncology Group Performance Status (ECOG-PS), instrumental activities of daily living (IADL), and Clinical Frailty Scale (CFS) at baseline. For evaluation of test-retest reliability, participants opted in to repeat ELFI, cognitive functioning scale, emotional functioning scale, and ECOG-PS 1 week later, as well as completing the Global Rating of Change. Internal consistency reliability was assessed using Cronbach's α and test-retest reliability was assessed using intraclass correlation (ICC). We assessed ELFI for convergent and discriminant validity (Spearman's r), known-groups validity (ANOVA), and structural validity (exploratory factor analysis). FINDINGS: Between May 6 and Dec 15, 2017, 877 participants with cancer returned a total of 869 baseline questionnaires and 482 retest questionnaires. 621 (71%) participants (192 [31%] aged ≥70 years) were included in evaluations of validity and internal consistency and 278 (32%) participants (106 [38%] aged ≥70 years) in evaluations of test-retest reliability. ELFI demonstrated excellent internal consistency reliability (Cronbach's α=0·93 for all participants; p<0·0001) and test-retest reliability (overall ICC 0·90, 95% CI 0·87-0·92; p<0·0001). Hypotheses regarding convergent and discriminant validity were confirmed, with all item-scale correlations exceeding 0·40 except for one on the physical functioning scale. ELFI was better than its component scales and other function measures at differentiating between groups with different function and frailty scores (known-groups validity). Exploratory factor analysis provided empirical support to the structural validity of ELFI. Strong correlation was observed between ELFI and its component scales (r ranging from 0·67 to 0·79), ECOG-PS (-0·79), IADL (0·69), and CFS (-0·73). INTERPRETATION: ELFI is a validated and simple person-reported multidimensional measure of functional status, which captures broad dimensions of functioning. ELFI has enhanced statistical efficiency relative to its components, reducing the sample size required to detect a given effect. ELFI could be used as a clinical trial endpoint to assess functional domains of health-related quality of life. FUNDING: National Health and Medical Research Council, Monash University, Eastern Health.

来源:Lancet Healthy Longev,查看原文。版权归原作者所有。

引用

  1. Soo WK, King M, Pope A, et al. The Elderly Functional Index (ELFI), a patient-reported outcome measure of functional status in patients with cancer: a multicentre, prospective validation study. Lancet Healthy Longev. 2020. PMID: 36098126. doi:10.1016/S2666-7568(20)30036-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。